3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Thyroid Nodule
1
Thyroid Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Neurofibrosarcoma
1
Malignant mesenchymal tumor
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangiosarcoma
1
Hemangiopericytoma, Malignant
1
Fibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Carcinoma, Lobular
1
COVID-19
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Interventions
Thyroidectomy
4
Iodine-131
4
trametinib
3
dabrafenib
3
apatinib
3
anlotinib
2
Surgical Procedures, Operative
2
Blood Specimen Collection
2
Biopsy, Large-Core Needle
2
toripalimab
1
tislelizumab
1
surufatinib
1
regorafenib
1
penpulimab
1
pembrolizumab
1
pazopanib
1
palbociclib
1
olaparib
1
lenvatinib
1
famitinib
1
camrelizumab
1
Ultrasonography
1
Thyroxine
1
Thyrotropin Alfa
1
Sunitinib
1
Second Harmonic Generation Microscopy
1
Routinely Collected Health Data
1
Rosiglitazone
1
Robotic Surgical Procedures
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Thyroid Neoplasms
×
Molecular Diagnostic Techniques
×
Clear all
NCT05323669
2022-04-12
MPTN
Belarusian State Medical University
Unknown
400 enrolled